UNSPSC 51285904: Dectaflur

This classification denotes a protective agent with the molecular formula C18H37N.FH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q3B1Y93C1S, chemically known as 9-octadecen-1-amine, hydrofluoride but more generally known as dectaflur, which bears US NIH Compound Identifier 6436136. European Medicines Agency schedules Dectaflur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06939MIG.

The term DECTAFLUR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). DECTAFLUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CCCCCCCCC=CCCCCCCCCN.F.

UNSPSC 51285904 Dectaflur is a Commodity code that encompasses pharmaceutical products used in public health response and community health initiatives, though recent state and local opportunities tagged under this code show a mismatch between the code's nominal scope and what is actually being procured. The Illinois Department of Public Health and Seminole County, Florida have posted or awarded contracts under this code for antibiotic pharmaceuticals (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and opioid-reversal medications (Naloxone), along with related drug deactivation systems. State and local buyers under this code include public health departments and county health agencies soliciting pharmaceutical supplies for emergency preparedness and community health programs. Issuance vehicles vary: Illinois used a piggyback arrangement through the MMCAP Infuse cooperative purchasing consortium, while Seminole County released a standalone IFB.

Recent activity is concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse contract to Chartwell Rx LLC over three years (12 months initial plus renewal options) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets via IFB 26-482DPH-PREPD-B-53392, with award announced August 28, 2026. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, with response deadline July 26, 2023 (noting a date discrepancy in the source record), seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually under a two-year contract with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the procurement includes FEMA compliance requirements and E-Verify mandates for vendor employees. No business enterprise program set-asides or domestic product preferences were applied to the Illinois award.